Raphael Pharmaceutical (RAPH) Payables (2020 - 2026)

Raphael Pharmaceutical has disclosed Payables across 7 years of filings, most recently posting $1.3 million for Q2 2026.

• In Q2 2026, Payables rose 132.27% year-over-year to $1.3 million; the TTM figure through Jun 2026 stood at $1.3 million (up 132.27% YoY), while the FY2025 annual figure was $1.1 million, up 214.16% from the prior year.
• Payables came in at $1.3 million for Q2 2026 at Raphael Pharmaceutical, up from $1.1 million in the prior quarter.
• In the past five years, Payables ranged from a high of $1.3 million in Q2 2026 to a low of $1000.0 in Q1 2022.
• Average Payables over 5 years is $331133.3, with a median of $107000.0 recorded in 2023.
• Year-over-year, Payables plunged 74.49% in 2022 and jumped 2069.23% in 2025.
• Over 5 years, Payables stood at $75000.0 in 2022, then jumped by 42.67% to $107000.0 in 2023, then soared by 229.91% to $353000.0 in 2024, then jumped by 214.16% to $1.1 million in 2025, then climbed by 18.12% to $1.3 million in 2026.
• Per Business Quant data, the three most recent Payables figures were $1.3 million in Q2 2026, $1.1 million in Q4 2025, and $755000.0 in Q3 2025.